human | Q5 |
P6178 | Dimensions author ID | 01331623740.48 |
P496 | ORCID iD | 0000-0001-8403-2234 |
P2038 | ResearchGate profile ID | Minouk-Schoemaker |
P2002 | X username | minouk_schoe |
P27 | country of citizenship | Kingdom of the Netherlands | Q29999 |
P106 | occupation | researcher | Q1650915 |
P5008 | on focus list of Wikimedia project | gender gap on Dutch Wikipedia | Q60687720 |
P21 | sex or gender | female | Q6581072 |
Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
Q93025301 | A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases |
Q43072092 | A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk |
Q36682471 | A genome-wide association study of early menopause and the combined impact of identified variants |
Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
Q37524853 | A novel approach to exploring potential interactions among single-nucleotide polymorphisms of inflammation genes in gliomagenesis: an exploratory case-only study |
Q89506041 | Adult weight change and premenopausal breast cancer risk: A prospective pooled analysis of data from 628,463 women |
Q34655215 | Allergic conditions and brain tumor risk |
Q48185601 | Allergy and glioma risk: test of association by genotype. |
Q48235089 | An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors |
Q43412423 | An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk |
Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
Q56089359 | Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women |
Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
Q43581448 | Body mass index, exercise, and other lifestyle factors in relation to age at natural menopause: analyses from the breakthrough generations study |
Q91002126 | Brain and Salivary Gland Tumors and Mobile Phone Use: Evaluating the Evidence from Various Epidemiological Study Designs |
Q62583499 | Breast Cancer Risk After Recent Childbirth |
Q62583508 | Breast cancer risk in relation to history of preeclampsia and hyperemesis gravidarum: Prospective analysis in the Generations Study |
Q64074174 | Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model |
Q46088775 | Breast density measurements with ultrasound tomography: a comparison with non-contrast MRI. |
Q57319691 | CASP8 D302H and meningioma risk: An analysis of five case-control series |
Q44288178 | CYP3A variation, premenopausal estrone levels, and breast cancer risk |
Q34560206 | Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study |
Q28269115 | Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study |
Q36740675 | Cancer risk in patients with constitutional chromosome deletions: a nationwide British cohort study |
Q50999553 | Changes in estradiol and testosterone levels in postmenopausal women after changes in body mass index. |
Q37630918 | Childhood body size and pubertal timing in relation to adult mammographic density phenotype |
Q28943530 | Chromosome 7p11.2 (EGFR) variation influences glioma risk |
Q56089366 | Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts |
Q48283361 | Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts |
Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
Q37681743 | Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study |
Q34399372 | Common genetic variants are significant risk factors for early menopause: results from the Breakthrough Generations Study |
Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
Q115209587 | Common variants in breast cancer risk loci predispose to distinct tumor subtypes |
Q28943376 | Common variation at 10p12.31 near MLLT10 influences meningioma risk |
Q92528444 | Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification |
Q62583503 | Comparative validation of breast cancer risk prediction models and projections for future risk stratification |
Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q57319766 | Comprehensive Analysis of DNA Repair Gene Variants and Risk of Meningioma |
Q55467579 | Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. |
Q89662330 | Correction to: Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study |
Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q97548420 | DNA methylation of the long intergenic noncoding RNA 299 gene in triple-negative breast cancer: results from a prospective study |
Q37685729 | DNA mismatch repair gene MSH6 implicated in determining age at natural menopause |
Q24633288 | Determinants of age at menarche in the UK: analyses from the Breakthrough Generations Study |
Q47642032 | Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study |
Q55110745 | E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. |
Q64078095 | Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer risk |
Q51766497 | Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation. |
Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
Q62583502 | Exposure to loud noise and risk of vestibular schwannoma: results from the INTERPHONE international case‒control study |
Q42596418 | Familial concordance for age at menarche: analyses from the Breakthrough Generations Study |
Q42598119 | Familial concordance for age at natural menopause: results from the Breakthrough Generations Study |
Q44611248 | Familial concordance for height and its components: analyses from the Breakthrough Generations Study |
Q38746332 | Family history and risk of breast cancer: an analysis accounting for family structure |
Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q114182808 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element |
Q46593237 | Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma |
Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
Q40137431 | Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium |
Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
Q29417068 | Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study |
Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q48345170 | Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma |
Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
Q29614921 | Genome-wide association study identifies five susceptibility loci for glioma |
Q36145972 | Genome-wide association study identifies multiple susceptibility loci for glioma |
Q61847493 | Genome-wide association study of anti-Müllerian hormone levels in pre-menopausal women of late reproductive age and relationship with genetic determinants of reproductive lifespan |
Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
Q38873936 | Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors |
Q114182677 | Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis |
Q37121271 | High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium |
Q34593492 | History of allergic disease and risk of meningioma |
Q40475089 | History of allergies and risk of glioma in adults. |
Q30252854 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer |
Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
Q52655627 | Impact of atopy on risk of glioma: a Mendelian randomisation study. |
Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
Q28383820 | Inherited variation in immune genes and pathways and glioblastoma risk |
Q40358881 | Interaction between 5 genetic variants and allergy in glioma risk |
Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
Q37265393 | Length of FMR1 repeat alleles within the normal range does not substantially affect the risk of early menopause |
Q55463059 | Location of gliomas in relation to mobile telephone use: a case-case and case-specular analysis. |
Q36896094 | Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. |
Q43543604 | Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment |
Q45920724 | MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. |
Q59830689 | Medical history, cigarette smoking and risk of acoustic neuroma: An international case-control study |
Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
Q48102990 | Mendelian randomisation study of the relationship between vitamin D and risk of glioma |
Q39855662 | Meningioma and mobile phone use--a collaborative case-control study in five North European countries |
Q37203133 | Menopausal hormone therapy and breast cancer: what is the true size of the increased risk? |
Q24651126 | Mobile phone use and risk of acoustic neuroma: results of the Interphone case-control study in five North European countries |
Q34574151 | Mobile phone use and risk of glioma in 5 North European countries |
Q30500761 | Mobile phone use and risk of glioma in adults: case-control study |
Q90391710 | Mortality and Cancer Incidence in Carriers of Balanced Robertsonian Translocations: A National Cohort Study |
Q62583498 | Mortality and cancer incidence in carriers of constitutional t(11;22)(q23;q11) translocations: A prospective study |
Q59291498 | Mortality and cancer incidence in males with Y polysomy in Britain: a cohort study |
Q47731327 | Mortality and cancer incidence in women with extra X chromosomes: a cohort study in Britain |
Q59291467 | Mortality in Women with Turner Syndrome in Great Britain: A National Cohort Study |
Q34456794 | Mortality in patients with Klinefelter syndrome in Britain: a cohort study |
Q59291487 | Mortality risks in patients with constitutional autosomal chromosome deletions in Britain: a cohort study |
Q92356825 | Night shift work and risk of breast cancer in women: the Generations Study cohort |
Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
Q35492571 | Non-fatal work related injuries in a cohort of Brazilian steelworkers. |
Q39006292 | Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
Q37555606 | Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q38494337 | Predictors of first nonfatal occupational injury following employment in a Brazilian steelworks |
Q37350137 | Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups |
Q37096858 | Psychological stress, adverse life events and breast cancer incidence: a cohort investigation in 106,000 women in the United Kingdom |
Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
Q64277598 | Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma |
Q62583506 | Reply to 'Comment on 'Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study" |
Q93106902 | Reply to Comment on: "Night shift work and risk of breast cancer in women: the Generations Study cohort" |
Q45960581 | Reply: Mobile phone use and acoustic neuroma in five North European countries. |
Q59291360 | Reproducibility of Estradiol and Testosterone Levels in Postmenopausal Women Over 5 Years: Results From the Breakthrough Generations Study |
Q48888372 | Reproductive factors and risk of meningioma and glioma. |
Q57452824 | Response to 'Comment on 'Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study" |
Q62583500 | Response to ‘Comment on ‘Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study” |
Q40390297 | Risk factors for pituitary tumors: a case-control study |
Q39877308 | Risk of pituitary tumors in cellular phone users: a case-control study |
Q28606408 | Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis |
Q59291440 | Secular trends in age at menarche in women in the UK born 1908-93: results from the Breakthrough Generations Study |
Q47870125 | Sex ratio in the offspring of parents with chronic radiation exposure from nuclear testing in Kazakhstan. |
Q47162371 | Smoking and risk of breast cancer in the Generations Study cohort |
Q44903190 | Temporal stability and determinants of white blood cell DNA methylation in the breakthrough generations study |
Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
Q35263089 | The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology |
Q23912478 | The INTERPHONE study: design, epidemiological methods, and description of the study population |
Q38370371 | The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium |
Q55466741 | The common D302H variant of CASP8 is associated with risk of glioma. |
Q42213216 | The relationship between obesity and exposure to light at night: cross-sectional analyses of over 100,000 women in the Breakthrough Generations Study |
Q37690092 | Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study |
Q91311927 | Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma |
Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
Q43559084 | Twinning in the offspring of parents with chronic radiation exposure from nuclear testing in Kazakhstan. |
Q92994868 | Two truncating variants in FANCC and breast cancer risk |
Q30356919 | Ultrasound Tomography Evaluation of Breast Density: A Comparison With Noncontrast Magnetic Resonance Imaging. |
Q59291476 | XRCC1 and XRCC3 variants and risk of glioma and meningioma |
Q122925830 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study |
Search more.